Edwards Lifesciences Corp (EW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q3 '16: 2.9B Q4 '16: 3B Q1 '17: 3.1B Q2 '17: 3.2B Q3 '17: 3.3B Q4 '17: 3.4B Q1 '18: 3.4B Q2 '18: 3.5B Q3 '18: 3.6B Q4 '18: 3.7B Q1 '19: 3.8B Q2 '19: 4B Q3 '19: 4.2B Q4 '19: 4.3B Q1 '20: 4.5B Q2 '20: 4.3B Q3 '20: 4.4B Q4 '20: 4.4B Q1 '21: 4.5B Q2 '21: 4.9B Q3 '21: 5.1B Q4 '21: 5.2B Q1 '22: 5.4B Q2 '22: 5.4B Q3 '22: 5.4B Q4 '22: 4.5B Q1 '23: 4.6B Q2 '23: 4.5B Q3 '23: 4.4B Q4 '23: 5.3B Q1 '24: 5.1B Q2 '24: 5.2B Q3 '24: 5.3B Q4 '24: 5.4B Q1 '25: 5.5B Q2 '25: 5.7B Q3 '25: 5.9B Q4 '25: 6.1B Q1 '26: 6.3B Q2 '26: 6.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 2B 4B 6B Q3 '16: 2.1B Q4 '16: 2.2B Q1 '17: 2.3B Q2 '17: 2.4B Q3 '17: 2.5B Q4 '17: 2.6B Q1 '18: 2.6B Q2 '18: 2.6B Q3 '18: 2.7B Q4 '18: 2.8B Q1 '19: 2.9B Q2 '19: 3B Q3 '19: 3.1B Q4 '19: 3.2B Q1 '20: 3.3B Q2 '20: 3.2B Q3 '20: 3.3B Q4 '20: 3.3B Q1 '21: 3.4B Q2 '21: 3.7B Q3 '21: 3.9B Q4 '21: 4B Q1 '22: 4.1B Q2 '22: 4.2B Q3 '22: 4.2B Q4 '22: 3.7B Q1 '23: 3.8B Q2 '23: 3.8B Q3 '23: 3.7B Q4 '23: 4.2B Q1 '24: 4.1B Q2 '24: 4.1B Q3 '24: 4.2B Q4 '24: 4.3B Q1 '25: 4.4B Q2 '25: 4.5B Q3 '25: 4.6B Q4 '25: 4.7B Q1 '26: 4.9B Q2 '26: 5.1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

0 600M 1.2B 1.8B Q4 '17: 1.1B Q1 '18: 1B Q2 '18: 1.1B Q3 '18: 1.1B Q4 '18: 748.2M Q1 '19: 769.9M Q2 '19: 785.3M Q3 '19: 830.7M Q4 '19: 1.1B Q1 '20: 1.2B Q2 '20: 793.5M Q3 '20: 857M Q4 '20: 897.6M Q1 '21: 923M Q2 '21: 1.6B Q3 '21: 1.7B Q4 '21: 1.7B Q1 '22: 1.7B Q2 '22: 1.7B Q3 '22: 1.7B Q4 '22: 1.5B Q1 '23: 1.4B Q2 '23: 1.3B Q3 '23: 1.2B Q4 '23: 1.4B Q1 '24: 1.3B Q2 '24: 1.4B Q3 '24: 1.4B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.5B Q3 '25: 1.4B Q4 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.4B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

0 1.5B 3B 4.5B Q3 '16: 551.7M Q4 '16: 569.5M Q1 '17: 656.7M Q2 '17: 716.2M Q3 '17: 744.9M Q4 '17: 583.6M Q1 '18: 560M Q2 '18: 656.6M Q3 '18: 712.4M Q4 '18: 722.2M Q1 '19: 765.3M Q2 '19: 724.9M Q3 '19: 773.7M Q4 '19: 1B Q1 '20: 1.1B Q2 '20: 743.6M Q3 '20: 794.1M Q4 '20: 823.4M Q1 '21: 851M Q2 '21: 1.5B Q3 '21: 1.5B Q4 '21: 1.5B Q1 '22: 1.5B Q2 '22: 1.5B Q3 '22: 1.5B Q4 '22: 1.5B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '23: 1.4B Q1 '24: 1.4B Q2 '24: 1.5B Q3 '24: 4.2B Q4 '24: 4.2B Q1 '25: 4.2B Q2 '25: 4.1B Q3 '25: 1.4B Q4 '25: 1.1B Q1 '26: 1.1B Q2 '26: 1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 500M 1B 1.5B Q3 '15: 601.7M Q4 '15: 617.2M Q1 '16: 661.5M Q2 '16: 705.4M Q3 '16: 760.1M Q4 '16: 797.4M Q1 '17: 832.7M Q2 '17: 841.3M Q3 '17: 853.2M Q4 '17: 875.3M Q1 '18: 893.3M Q2 '18: 928.4M Q3 '18: 940M Q4 '18: 939.4M Q1 '19: 937.6M Q2 '19: 995.4M Q3 '19: 1.1B Q4 '19: 1.1B Q1 '20: 1.1B Q2 '20: 1.1B Q3 '20: 1.1B Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.2B Q3 '21: 1.2B Q4 '21: 1.2B Q1 '22: 1.3B Q2 '22: 1.2B Q3 '22: 1.1B Q4 '23: 1.1B Q1 '24: 1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.2B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.4B Q2 '26: 1.4B Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

0 600M 1.2B 1.8B Q3 '16: 607.1M Q4 '16: 704.4M Q1 '17: 725.6M Q2 '17: 733M Q3 '17: 837.9M Q4 '17: 1B Q1 '18: 1B Q2 '18: 966.2M Q3 '18: 997.7M Q4 '18: 926.7M Q1 '19: 776.9M Q2 '19: 977.9M Q3 '19: 1.1B Q4 '19: 1.2B Q1 '20: 1.4B Q2 '20: 1.3B Q3 '20: 1.1B Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.4B Q3 '21: 1.8B Q4 '21: 1.7B Q1 '22: 1.7B Q2 '22: 1.5B Q3 '22: 1.3B Q4 '22: 1.2B Q1 '23: 1.2B Q2 '23: 940.4M Q3 '23: 1B Q4 '23: 895.8M Q1 '24: 528.2M Q2 '24: 866.1M Q3 '24: 806.4M Q4 '24: 542.3M Q1 '25: 876.2M Q2 '25: 794.9M Q3 '25: 1B Q4 '25: 1.6B Q1 '26: 1.4B Q2 '26: 1.7B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 500M 1B 1.5B Q3 '16: 456.7M Q4 '16: 528.3M Q1 '17: 561.3M Q2 '17: 547.8M Q3 '17: 658.5M Q4 '17: 832.6M Q1 '18: 828.3M Q2 '18: 776M Q3 '18: 764.7M Q4 '18: 688M Q1 '19: 539.2M Q2 '19: 728.4M Q3 '19: 832.4M Q4 '19: 928.5M Q1 '20: 1.1B Q2 '20: 940.5M Q3 '20: 692.1M Q4 '20: 647.3M Q1 '21: 716.9M Q2 '21: 1.1B Q3 '21: 1.4B Q4 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.3B Q3 '22: 1B Q4 '22: 973.6M Q1 '23: 1B Q2 '23: 702.2M Q3 '23: 808.4M Q4 '23: 642.8M Q1 '24: 271.4M Q2 '24: 571.8M Q3 '24: 515.5M Q4 '24: 289.9M Q1 '25: 633.1M Q2 '25: 587.9M Q3 '25: 804.2M Q4 '25: 1.3B Q1 '26: 1.1B Q2 '26: 1.4B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 250M 500M 750M Q2 '13: 114.7M Q3 '13: 112.9M Q1 '14: 108.5M Q2 '14: 107.4M Q3 '14: 108.4M Q1 '15: 220.6M Q2 '15: 219.9M Q3 '15: 219.9M Q1 '16: 217.8M Q2 '16: 217.3M Q3 '16: 218.1M Q1 '17: 216.4M Q2 '17: 215.7M Q3 '17: 216.2M Q1 '18: 215.1M Q2 '18: 214M Q3 '18: 213.2M Q1 '19: 212.2M Q2 '19: 636.2M Q3 '19: 636.3M Q1 '20: 635.1M Q2 '20: 620.3M Q3 '20: 631M Q1 '21: 631.3M Q2 '21: 629.9M Q3 '21: 631.7M Q1 '22: 629.4M Q2 '22: 626.7M Q3 '22: 624.5M Q1 '23: 610.9M Q2 '23: 610.3M Q3 '23: 609.5M Q1 '24: 604.1M Q2 '24: 604.3M Q3 '24: 598.1M Q1 '25: 587.8M Q2 '25: 587.9M Q3 '25: 585.7M Q1 '26: 580.7M Q2 '26: 577.6M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '16: 2.53 Q4 '16: 2.62 Q1 '17: 3.02 Q2 '17: 3.30 Q3 '17: 3.44 Q4 '17: 2.70 Q1 '18: 2.60 Q2 '18: 3.06 Q3 '18: 3.33 Q4 '18: 3.37 Q1 '19: 3.59 Q2 '19: 2.65 Q3 '19: 2.02 Q4 '19: 2.43 Q1 '20: 1.74 Q2 '20: 1.16 Q3 '20: 1.25 Q4 '20: 1.30 Q1 '21: 1.35 Q2 '21: 2.33 Q3 '21: 2.35 Q4 '21: 2.39 Q1 '22: 2.44 Q2 '22: 2.31 Q3 '22: 2.32 Q4 '22: 2.44 Q1 '23: 2.41 Q2 '23: 2.26 Q3 '23: 2.34 Q4 '23: 2.30 Q1 '24: 2.32 Q2 '24: 2.43 Q3 '24: 6.93 Q4 '24: 6.97 Q1 '25: 7.00 Q2 '25: 6.95 Q3 '25: 2.32 Q4 '25: 1.83 Q1 '26: 1.88 Q2 '26: 1.74 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.